Literature DB >> 28878924

Serpentine supravenous hyperpigmentation.

Indirakshi Jamalpur1, Harikrishna Reddy Mogili2, Abhilash Koratala3.   

Abstract

Serpentine supravenous hyperpigmentation is a peculiar cutaneous eruption that follows the path of vein after intravenous injection of the chemotherapeutic agent. The lesions gradually resolve spontaneously if administration of the offending agent is stopped through the affected limb. Drugs such as 5-fluorouracil, docetaxel, vinorelbine, hydroxychloroquine, fotemustine, and minocycline are implicated.

Entities:  

Keywords:  Chemotherapy; docetaxel; serpentine supravenous hyperpigmentation

Year:  2017        PMID: 28878924      PMCID: PMC5582224          DOI: 10.1002/ccr3.1102

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


A 30‐year‐old Asian Indian woman with history of breast cancer has presented with blackish discoloration above the site of intravenous access on right forearm [Fig. 1A] after 1 week of infusion of docetaxel through a peripheral venous catheter. She was recently started on palliative single agent chemotherapy with docetaxel 75 mg/m2 for metastatic disease and did not have a central venous port. We diagnosed the rash as serpentine supravenous hyperpigmentation secondary to docetaxel. In addition, she was also noted to have other dermatologic manifestations of docetaxel, namely blackish discoloration of the palms [Fig. 1C], horizontal banding and pigmentation of nails [Fig. 1B], and alopecia 1, 2, 3, 4.
Figure 1

(A) Hyperpigmentation along the superficial veins of the forearm. (B) Horizontal banding and pigmentation of nails. (C) Blackish discoloration of the palms.

(A) Hyperpigmentation along the superficial veins of the forearm. (B) Horizontal banding and pigmentation of nails. (C) Blackish discoloration of the palms.

Authorship

All the authors made substantial contribution to the preparation of this manuscript and approved the final version for submission. IJ: procured the images and drafted manuscript; HM: drafted manuscript; AK: reviewed and revised the manuscript for critically important intellectual content.

Conflict of Interest

The authors have declared that no conflict of interest exists.

Informed Consent

Informed consent has been obtained for the publication of this clinical image.
  4 in total

1.  Images in clinical medicine. Serpentine supravenous hyperpigmentation.

Authors:  Chih-Chieh Chan; Sung-Jan Lin
Journal:  N Engl J Med       Date:  2010-07-29       Impact factor: 91.245

Review 2.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

Review 3.  Mucocutaneous reactions to chemotherapy.

Authors:  W S Susser; D L Whitaker-Worth; J M Grant-Kels
Journal:  J Am Acad Dermatol       Date:  1999-03       Impact factor: 11.527

4.  Persistent serpentine supravenous hyperpigmented eruption associated with docetaxel.

Authors:  I Aydogan; A Kavak; A H Parlak; M Alper; A N Annakkaya; M Erbas
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-05       Impact factor: 6.166

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.